These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34834529)

  • 1. LASSO and Bioinformatics Analysis in the Identification of Key Genes for Prognostic Genes of Gynecologic Cancer.
    Yu SH; Cai JH; Chen DL; Liao SH; Lin YZ; Chung YT; Tsai JJP; Wang CCN
    J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
    Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis.
    Zhao H; Jiang A; Yu M; Bao H
    J Cell Biochem; 2020 Dec; 121(12):4908-4921. PubMed ID: 32692884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.
    Liu Y; Hua T; Chi S; Wang H
    Oncol Lett; 2019 Jan; 17(1):897-906. PubMed ID: 30655845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer.
    Ma Y; Zhang X; Yang J; Jin Y; Xu Y; Qiu J
    Front Oncol; 2022; 12():854615. PubMed ID: 35392242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics prediction and analysis of hub genes and pathways of three types of gynecological cancer.
    Liu Y; Yi Y; Wu W; Wu K; Zhang W
    Oncol Lett; 2019 Jul; 18(1):617-628. PubMed ID: 31289534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.
    Lv S; Xu X; Wu Z
    Oncol Lett; 2019 Dec; 18(6):6679-6689. PubMed ID: 31807178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis.
    Dai F; Chen G; Wang Y; Zhang L; Long Y; Yuan M; Yang D; Liu S; Cheng Y; Zhang L
    Onco Targets Ther; 2019; 12():4517-4532. PubMed ID: 31354287
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
    Zhong G; Lou W; Shen Q; Yu K; Zheng Y
    Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.